Personally, I don't think the dosing of the first patient will...

Personally, I don't think the dosing of the first patient will have much of an effect on whatever the SP is doing that week. I think the recent rises are, in part, pricing the start of the trials in already. There will be some who sell the news, but I think this will be offset by a minor increase in interest. I think we will continue to see phases of solid increases and consolidation for a couple of months yet.
I think results are what will really start to drive the SP up into the $5-$10 range, assuming the results are positive.
Having said all that, BLT has surprised me thus far (in a good way), so I could be completely wrong (again). I'm glad I've been fully loaded for over a month and I don't need to lose any more sleep over trying to buy in on the dips. Now I just need to wait for payday :)